hello

What Makes Biotech Different: The Unique Informatics Challenge

Before examining what biotech laboratory software needs to deliver, it is important to understand why biotechnology presents a distinctly different informatics challenge from other industries.

Biotech laboratories handle sample types and workflow complexity that have no equivalent in other sectors. Biological samples, such as cell lines, tissue samples, plasmids, viral vectors, serum specimens, and patient-derived materials have unique provenance, storage, and handling requirements. Each has a chain of custody that must be maintained from source to study completion.

Biotech research workflows are also inherently iterative and non-linear, unlike the structured QC workflows of pharmaceutical manufacturing. A scientist running a protein expression optimisation experiment may modify the protocol six times in two weeks, each modification producing a new dataset that must be linked to the previous version for the study to be scientifically reproducible. Without structured digital documentation, this iterative data accumulates in personal notebooks and individual spreadsheets that no one else can reliably access or interpret.

The regulatory dimension adds further complexity. Biotech companies advancing candidates toward clinical development operate under GLP for non-clinical safety studies, GCP for clinical trials, and GMP for manufacturing. Each of these frameworks places specific requirements on how data is recorded, who can access it, how it is changed, and how it is retained. A biotech laboratory information management system (LIMS) software that is not built to meet these regulatory standards from the ground up creates a compliance liability.

Why Biotech Companies Need a Modern Laboratory Informatics Platform

Centralised Sample Management

The volume and diversity of biological samples managed by a biotech company over the lifecycle of a single program is enormous. Hundreds of cell line vials, thousands of serum samples from preclinical studies, stability specimens stored at multiple temperature conditions, reference standards, and patient-derived materials from clinical trials all need to be tracked, located, and retrieved reliably across years of research and development activity.

A modern biotech LIMS provides a structured biorepository management capability that tracks every sample through a physical storage hierarchy with barcode-based identification and chain-of-custody documentation at every stage. Scientists can locate any sample in the system within seconds, and know exactly how much remains, see its full history of usage, and document its retrieval and return without a paper logbook.